Henze, G., Mikhailova, E., Popov, A., Roumiantseva, J., Budanov, O., Lagoyko, S., . . . Karachunskiy, A. Blinatumomab as postremission therapy replaces consolidation and substantial parts of maintenance chemotherapy and results in stable MRD negativity in children with newly diagnosed B-lineage ALL. BMJ Publishing Group.
Chicago Style (17th ed.) CitationHenze, Guenter, et al. Blinatumomab as Postremission Therapy Replaces Consolidation and Substantial Parts of Maintenance Chemotherapy and Results in Stable MRD Negativity in Children with Newly Diagnosed B-lineage ALL. BMJ Publishing Group.
MLA (9th ed.) CitationHenze, Guenter, et al. Blinatumomab as Postremission Therapy Replaces Consolidation and Substantial Parts of Maintenance Chemotherapy and Results in Stable MRD Negativity in Children with Newly Diagnosed B-lineage ALL. BMJ Publishing Group.